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Abstract 
Background: Malaria control in Tanzania currently relies primarily on long-lasting insecticidal nets and indoor 
residual spraying, alongside effective case management and behaviour change communication. This study explored 
opinions of key stakeholders on the national progress towards malaria elimination, the potential of currently available 
vector control interventions in helping achieve elimination by 2030, and the need for alternative interventions that 
could be used to supplement malaria elimination efforts in Tanzania.
Methods: In this exploratory qualitative study, Focus group discussions were held with policy-makers, regulators, 
research scientists and community members. Malaria control interventions discussed were: (a) improved housing, (b) 
larval source management, (c) mass drug administration (MDA) with ivermectin to reduce vector densities, (d) release 
of modified mosquitoes, including genetically modified or irradiated mosquitoes, (e) targeted spraying of mosquito 
swarms, and (f ) spatial repellents.
Results: Larval source management and spatial repellents were widely supported across all stakeholder groups, 
while insecticide-spraying of mosquito swarms was the least preferred. Support for MDA with ivermectin was high 
among policy makers, regulators and research scientists, but encountered opposition among community members, 
who instead expressed strong support for programmes to improve housing for poor people in high transmission 
areas. Policy makers, however, challenged the idea of government-supported housing improvement due to its per-
ceived high costs. Techniques of mosquito modification, specifically those involving gene drives, were viewed posi-
tively by community members, policy makers and regulators, but encountered a high degree of scepticism among 
scientists. Overall, policy-makers, regulators and community members trusted scientists to provide appropriate advice 
for decision-making.
Conclusion: Stakeholder opinions regarding alternative malaria interventions were divergent except for larval 
source management and spatial repellents, for which there was universal support. MDA with ivermectin, housing 
improvement and modified mosquitoes were also widely supported, though each faced concerns from at least one 
stakeholder group. While policy-makers, regulators and community members all noted their reliance on scientists to 
make informed decisions, their reasoning on the benefits and disadvantages of specific interventions included factors 
beyond technical efficiency. This study suggests the need to encourage and strengthen dialogue between research 
scientists, policy makers, regulators and communities regarding new interventions.
© The Author(s) 2020. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, 
adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and 
the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material 
in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material 
is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the 
permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creat iveco 
mmons .org/licen ses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creat iveco mmons .org/publi cdoma in/
zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Open Access
Malaria Journal
*Correspondence:  lfinda@ihi.or.tz
1 Environmental Health and Ecological Sciences Department, Ifakara 
Health Institute, P. O. Box 53, Ifakara, Tanzania
Full list of author information is available at the end of the article
Page 2 of 13Finda et al. Malar J          (2020) 19:164 
Background
Morbidity and mortality due to malaria has significantly 
declined worldwide over the past two decades, most sig-
nificantly in sub Saharan Africa [1, 2]. Between 2000 and 
2017 the number of malaria cases recorded in the region 
has decreased by 41%, and mortality by 62%, a success 
attributable to both public health efforts and improve-
ments in socioeconomic conditions [1]. In Tanzania, 
malaria prevalence has gone down by more than 50% 
over the past decade, from 18% in 2008 to just 7.3% in 
2017, mainly as a result of near universal coverage with 
long-lasting insecticide-treated bed nets (LLINs), indoor 
residual sprays (IRS), reliable and affordable diagnosis 
and treatment, and improved livelihoods [3].
The interventions behind this success in malaria con-
trol are however rapidly reaching their limits, as malaria 
continues to persist. A significant slowdown in the 
decline of malaria cases and deaths has been observed 
over the past decade; between 2010 and 2018, the rate of 
malaria cases and deaths have only declined by 22% and 
30%, respectively [2]. Mosquito resistance to insecticides 
used in indoor residual spraying and bed nets is now 
widely documented worldwide [4, 5]. An increasing dis-
position of malaria vector to bite during the early-even-
ing hours and the early morning, and to do so outdoor, 
is also well documented [6, 7], threatening the success of 
the major interventions for malaria control. Plasmodium 
resistance to the commonly used drugs is also increas-
ingly evident across Africa and Asia [8, 9], further threat-
ening the progress.
In 2015, the World Health Assembly adapted the 
Global Technical Strategy for Malaria 2016–2030, which 
aimed to provide a framework to reduce malaria inci-
dence and mortality by 90% worldwide by 2030, and 
to eliminate malaria in 35 countries by the same year 
[10]. Tanzania is one of the countries currently pursu-
ing malaria elimination by 2030, building on the signifi-
cant gains achieved since the late 1990s [11]. To achieve 
malaria elimination, the National Malaria Control Pro-
gramme has adopted a strategy to ensure adequate cover-
age of vector control interventions, primarily the use of 
LLINs and IRS [11]. The strategy also includes improved 
malaria diagnosis and case management, as well as roll-
out of new complementary interventions where there is 
sufficient local evidence for impact [11].
Several complementary vector control interventions 
are currently being discussed as possible candidates to 
accelerate the malaria elimination efforts [12]. Examples 
include: (a) larval source management (LSM), including 
larviciding and environmental management [13, 14], 
(b) topical repellents for personal protection [15, 16], 
(c) mass drug administration with endectocides such 
as ivermectin [17, 18], (d) use of mosquito modification 
techniques, either to suppress or replace vector popula-
tions [19, 20], (e) outdoor targeting of male mosquitoes 
through insecticide-spraying of mosquito swarms [21–
23], (f ) housing improvement measures such as better 
window screening and improved house designs [24–26], 
(g) spatial repellents able to protect multiple individuals 
over wide areas [27, 28], (h) attractive toxic sugar baits 
targeting sugar-seeking mosquitoes [29, 30], and (i) mos-
quito-killing fungal spores and toxins [31, 32].
Unfortunately, most of these interventions are not 
ready for deployment at scale; significant investments, 
as well as strong multi-sectorial collaborations will be 
needed to complete their development and evaluation. 
To ensure that these potential alternative interventions 
meet user needs and are sustainable, it is crucial to con-
sider, early on in their development, the views and opin-
ions of key stakeholders. This study sought to explore 
opinions of key stakeholders regarding Tanzania’s pro-
gress towards malaria elimination, the potential of cur-
rently available vector control interventions to achieve 
elimination by 2030, and the potential and acceptability 
of additional vector control interventions that could sup-
plement current elimination efforts. This study is a part 
of a larger investigation seeking to assess the awareness 
and perceptions of alternative strategies for malaria con-
trol and elimination in Tanzania, and to design appropri-
ate pathways for the development of new intervention 
packages.
Methods
Study site and stakeholder selection
This study was done in Tanzania between December 2018 
and May 2019, and involved four groups of stakeholders: 
(a) policy-makers, (b) regulators, (c) research scientists, 
and (d) community members. The stakeholders were all 
involved either directly or indirectly in malaria control in 
Tanzania.
Research scientists were selected from two leading 
research institutes in the country: Ifakara Health Insti-
tute (IHI), and National Institute for Medical Research 
(NIMR). The group included entomologists, economists, 
health systems and policy researchers, molecular biolo-
gists and ethicists involved in the design of malaria con-
trol strategies in Tanzania. The group of policy-makers 
included senior officials from government ministries 
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in Dodoma, Tanzania’s administrative capital, all of 
them with direct or indirect influence on malaria con-
trol activities. The government ministries represented 
were: (a) Ministry of Health, Community Development, 
Gender, Elderly and Children, (b) Ministry of Education 
and Vocational Training, (c) Ministry of Agriculture, (d) 
Ministry of Livestock and Fisheries Development, (e) 
Ministry of Water and Irrigation, (f ) Ministry of Hous-
ing and Infrastructure and (g) President’s Office-Regional 
Administration and Local Government. The group of 
regulators included officials from the Tanzania Medicines 
& Medical Devices Authority, the Tanzania Commission 
for Science and Technology, and the National Environ-
mental Management Committee.
Lastly, community members were comprised of local 
community leaders drawn from 10 rural and urban wards 
in Ulanga and Kilombero districts in the Kilombero val-
ley, in south-eastern Tanzania. Residents in the area are 
mostly subsistence farmers, pastoralists or small business 
owners [33, 34]. Malaria prevalence in these districts is 
highly heterogeneous, ranging from < 1% in the urban 
and peri-urban sites to > 40% in some of the villages 
(Swai et  al., unpublished). Transmission intensities are 
also highly diverse, varying from less than 1 to ~ 20 infec-
tious bites per person per year [33, 34].
Study procedures and interventions evaluated
This was an exploratory qualitative study; moder-
ated Focus group discussions (FGDs) [35] were used to 
explore opinions of the stakeholders on the suitability and 
potential of alternative interventions. The alternatives 
discussed were: (a) improved housing, (b) larval source 
management, (c) mass drug administration (MDA) with 
ivermectin to reduce vector densities, (d) release of mod-
ified mosquitoes, including genetically modified strains, 
(e) targeted spraying of mosquito swarms, and (f ) spatial 
repellents. These interventions were selected because 
of their pertinence for policy discussions, whether it 
is being considered for large scale implementation for 
malaria vector control in the country, undergoing large 
clinical trials in the country, or gaining interest world-
wide as potential tools to help achieve malaria elimina-
tion. Table  1 shows summaries of these interventions, 
including some evidence on their potential.
A total of eight focus group discussion sessions, two 
per stakeholder group, were conducted, each with 6–10 
participants. During the FGDs with community mem-
bers, men and women were separated to maximize the 
participation of women [35]. This separation was con-
sidered unnecessary for the other stakeholder groups. 
To avoid framing the discussions too narrowly, a semi-
structured discussion guide was used. Participants were 
first asked open-ended questions about their opinions 
on the country’s progress towards malaria elimination, 
their views on the effectiveness of current malaria con-
trol interventions, and the need for alternative interven-
tions for malaria control. The facilitator then presented a 
brief overview of the alternative interventions for malaria 
elimination, by way of PowerPoint slides. The presenta-
tions were delivered in English with the expert groups, 
but the language was adapted to Swahili (the main lan-
guage spoken in Tanzania) for the two FGDs with com-
munity members. Participants were given time to ask 
questions following the presentation of each interven-
tion, and when they were satisfied with the answers the 
discussions about that specific interventions began. 
The FGD sessions lasted 120–150  min each and were 
audio-recorded with participants’ consent. Additionally, 
detailed notes were taken during the discussions.
Participants from each stakeholder group were pur-
posively selected with help from their institutional lead-
ers. It was important that stakeholders with expertise 
in malaria control were identified. With regards to the 
experts, invitation letters were sent to heads of institu-
tions were the participants were based, and these heads 
then recommended staff members for the discussions. 
With the community members, ten wards were randomly 
selected in the Kilombero Valley in south-eastern Tan-
zania, and invitation letters were sent to ward leaders to 
recommend one male and one female community leaders 
to participate in the discussions.
The discussions were facilitated by two research sci-
entists from Ifakara Health Institute, both of whom have 
extensive knowledge of malaria control. While the sci-
entists were known to some of the participants because 
of their work, there were no subordinate relationships 
between facilitators and participants. FGDs with research 
scientists and policy makers were undertaken in their 
respective institutes. In the case of community members 
and regulators, the discussions were done centrally at Ifa-
kara Health Institute offices. The feedback sessions were 
also done at Ifakara Health Institute.
Data processing and analysis
Audio recordings of the FGDs were transcribed imme-
diately following the discussions, then translated from 
Swahili to English when needed. Field notes were incor-
porated in the written transcripts as additional data. The 
final transcripts were reviewed in detail then imported 
to Nvivo 12 Plus software [36] for further processing and 
analysis. Deductive analysis was used to categorize codes 
based on the FGD guide, which explored participants’ 
opinions on: (a) the country’s progress towards malaria 
elimination, (b) potential of current interventions for 
malaria elimination, (c) need for alternative approaches 
and techniques to support elimination efforts, (d) 
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potential of the alternative interventions, and (e) their 
potential applications as complementary interventions in 
the efforts towards the 2030 malaria elimination target. 
Preliminary findings of the study were presented back to 
the participants. Quotes from participants were used to 
support the themes.
Results
Altogether, 60 people participated in the FGD discussions 
from across the stakeholder groups, 33 of whom were 
males and 27 females. Demographic characteristics of the 
FGD participants are presented on Table  2. Results on 
the opinions of key stakeholders of malaria elimination in 
Tanzania  are presented based on the  FGD guide points 
listed on the “Data processing and analysis” section.
Opinions on progress towards malaria elimination 
in Tanzania
Research scientists, regulators and policy makers 
discussed the progress made by Tanzania towards 
malaria elimination in terms of declining rates of 
Table 1 Descriptions of  alternative interventions to  complement current malaria control and  elimination efforts, 
as discussed with key stakeholders in Tanzania
Intervention Description
Improved housing House improvement as malaria control intervention involves mosquito-proofing houses to limit mosquito 
entrance into the house [26, 37]. General housing improvement was a key factor in the elimination of 
malaria in developed countries [24]. In developing countries, simple modifications like screening windows 
and doors and closing eave spaces have resulted in some cases, in a 50% decline in entomological inocula-
tion rates [38]. In Tanzania for example, housing improvement was linked to significant historical declines 
of malaria in Dar es Salaam [39], and was likely a major factor in more than 99% decline in malaria in Ifakara 
town, the main town in the area of our study [33]
Larval source management Larval source management (LSM) refers to environmental manipulations to target mosquito larval habitats 
[13]. LSM can include the use of larvicides as well as environmental management methods [13, 14, 40]. In 
Tanzania, large-scale larviciding resulted in 21% reduction in malaria prevalence in Dar es Salaam between 
2006 and 2008 [41]. The Tanzanian government is currently conducting targeted larviciding in urban and 
rural settings as a means to reduce malaria incidence and speed up the elimination agenda [42]
Mass drug administration of ivermectin Ivermectin is an anti-helminthic drug commonly used to control parasitic nematodes in humans and 
animals [43]. It has been extensively used in mass campaigns for the elimination of lymphatic filariasis and 
onchocerciasis in Tanzania [44, 45]. Ivermectin is currently being evaluated as a malaria control tool, since 
it significantly reduces female mosquito fecundity and survival when mosquitoes blood-feed on hosts that 
have taken the drug [18, 43, 46]
Targeted spraying of mosquito swarms Male mosquitoes aggregate in swarms as they compete for attention of female mosquitoes searching for 
mating partners [47]. Swarms usually occur at approximately the same time, usually at sunset, and repeat-
edly at same locations throughout the year [47]. Studies done in Burkina Faso and Tanzania have shown that 
Anopheles mosquito swarms can be located and targeted, and are effective in reducing overall mosquito 
density [21–23]
Modified mosquitoes This intervention refers to alterations of mosquito genes or physiology for the purpose of reducing their com-
petence in diseases transmission. The modified mosquitoes are released into the environment so that they 
can interbreed with the wild mosquitoes and, depending on the trait they carry, either reduce the density 
of malaria vectors or replace its population with mosquitoes unable to transmit the pathogen. Interven-
tions currently under study include Sterile Insect-technique, which relies on irradiation of mosquitoes to 
make them sterile [48], genetic modification of mosquitoes to introduce sterility or other disadvantageous 
traits [49], and use of gene drive systems to spread novel traits (e.g. lethality or refractoriness to pathogen 
transmission) in mosquito populations [19, 50]. While the technology has never been integrated into a 
malaria control programme, laboratory studies, mathematical models and preliminary field trials indicate its 
potential [51]
Spatial repellents Spatial repellents prevent host-seeking mosquitoes from entering certain areas, thus limiting contact between 
humans and mosquitoes [27]. SP can be based on a variety of botanical products and chemical compounds, 
such as citronella, transfluthrin and metofluthrin [27, 52]. They can be delivered in different formats, such as 
mosquito coils, repellent-treated clothing, repellent sandals (Finda et al. unpublished), kerosene lamps [53], 
and eave ribbons [27, 28, 54]. Compared to widely available topical repellents, some SP can provide long-
lasting repellency, requiring minimal participation from the users
Table 2 Gender distribution of  the  participants of  Focus 
group discussions
Stakeholder group Males Females Total
Community members 8 8 16
Policy makers 7 8 15
Regulators 7 7 14
Research scientists 11 4 15
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malaria prevalence. Community members in con-
trast, discussed the progress in terms of their daily life 
experiences.
Two major arguments emerged in relation to this issue 
across the stakeholder groups. On the one hand, it was 
agreed that the country had made good progress and was 
on the right track. On the other hand, it was similarly 
noted that the progress was too slow and inadequate for 
elimination by 2030 as planned. Participants who empha-
sized that the country was on track referred to the sig-
nificant reduction in malaria prevalence over the past 
decade, noting that malaria has reduced by more than 
50% since 2000. As one policy maker stated:
“Of course we have come far from when prevalence 
was as high as 20% in the whole country. Back then, 
when you look at the map, it was all red, all red I tell 
you. There was malaria everywhere. But now you 
can see quite a lot of places that have prevalence of 
less than 1%, so when I see that I know that we are 
doing well.” (Policy-maker; female).
For community members, their idea of progress was 
informed mostly by their lived experiences. They noted, 
for example, that the frequency and severity of malaria 
attacks has greatly declined over the years. Unlike in the 
past, when malaria infections were very frequent, several 
months could now go by without their children getting 
sick. And when they did get sick, it was likely not to be 
malaria. As one participant said:
“Ten years back there was a lot of malaria. During 
that time, every time you did not feel well and went 
to the hospital you would be told that you have 
malaria. Kids were getting sick very often. But now 
we can go for even six months without our children 
getting sick or needing to go to the hospital. And 
when we do go we hear about other diseases, like 
urinary tract infections or typhoid. So then I know 
that malaria is not a big disease like it used to be.” 
(Community members; female).
Some participants, particularly policy makers and 
research scientists asked for caution, noting that, while 
there has been significant progress, it was nevertheless 
too slow and did not reflect the amount of effort that the 
country was putting into place. They also noted that the 
decline in malaria prevalence was not uniform across the 
country. As one policy maker reported:
“I think we are doing well, but not as well as I 
would like. As a country we have put a great deal 
of efforts to finish off this disease, but I am sad 
to see that there are areas in the country where 
prevalence is as high as 40%. We should not be in a 
situation like this.” (Policy maker; male).
Opinions on the potential of current interventions 
for malaria elimination
Two main viewpoints were expressed regarding the 
potential of current interventions in leading the coun-
try to elimination by 2030. One viewpoint, expressed 
by a majority of participants across the stakeholder 
groups, was that current interventions would not be 
sufficient to achieve elimination, even if they were uti-
lized fully and effectively. One key reason given was 
that current interventions do not address growing chal-
lenges, such as insecticide resistance, or changes in 
mosquito biting behaviours. As one community mem-
ber explained
“I really do not think that the insecticide-sprays or 
the bed nets are enough, because if they were enough 
we would not have malaria anymore. I sleep under 
a bed net every night, but mosquitoes still bite me 
when I am outside cooking or chatting with my 
family and friends. Sometimes I also spray my house 
with insecticides, but when I go inside to sleep, I see 
there are mosquitoes still. So then I know that these 
sprays are useless.” (Community member, female).
The opposite viewpoint was also expressed, namely 
that currently available interventions would be enough 
for elimination if they were utilized to their maximum 
potential. As pointed out by one research scientist:
“We already have what it takes to achieve 
elimination. If bed nets were properly made, properly 
distributed and properly used, why would we not 
eliminate the disease? If they killed mosquitoes as 
they are supposed to, if the universal distribution 
was actually universal, and if people actually 
slept under bed nets, I do not think we would need 
anything else…” (Scientist, female).
Other participants pointed out that the current 
interventions are passive rather than active. That 
is, they only target female mosquitoes coming into 
human dwellings to feed, rather than actively targeting 
mosquitoes in their larval habitats and hiding places. As 
one policy maker stated:
“We need means to target and eliminate all the 
mosquitoes, not just the ones that get inside the 
house. If we decide to kill mosquitoes, then we should 
really kill all of them. We should target them at 
larval stage and adult stage to make sure that we 
are not leaving any windows for escape.” (Policy 
maker, male).
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Opinions on the need for alternative interventions 
for malaria elimination
There were diverse inputs from participants on the need 
for complementary interventions for malaria elimina-
tion in Tanzania, although a majority participants agreed 
that it would be necessary to complement strategies. The 
insights that emerged most clearly were: (a) the impor-
tance of learning from countries that have been suc-
cessful in achieving elimination; (b) the importance of 
knowing more about current interventions, including 
where or why they have failed or succeeded; and (c) the 
need to consider combinations of interventions as a more 
holistic approach to achieve malaria elimination.
Those participants who emphasized the value of learn-
ing from other successful countries argued that there was 
no need to develop interventions from scratch, and that 
the country should follow in the footsteps of those who 
had been successful in eliminating malaria. Other par-
ticipants noted that, since malaria prevalence was not 
homogeneous across the country, it would be essential to 
employ different interventions in different settings based 
on the specific conditions. As one participant from the 
regulators’ group stated:
“Malaria prevalence is not the same in all the 
country. There are parts of the country that are 
near elimination, and there are parts that have 
prevalence in double digits. This should tell you 
that one single method is not enough for the whole 
country. You need to look at different places and 
figure out what can work where.” (Regulator, 
female).
Participants who recommended combinations of 
interventions argued that we now have greater knowledge 
of mosquito behaviours than in the past, and that this 
knowledge can be used to target them from multiple 
angles to accelerate elimination. In one of the policy-
makers’ FGDs, one participant noted that:
“In order to really eliminate mosquitoes we need 
a combination of different strategies…We need to 
target all the water bodies to get rid of the larval 
stages, then all the hiding places like long grass and 
bushes, and then in the houses where they go to look 
for people to bite. If we do all of this, can you tell 
me how we can still have malaria in our country?” 
(Policy-maker, male).
There were also participants who suggested that it was 
not wise to rush to new interventions without learning 
from the limitations of the current ones, and possibly 
addressing those first. In one session with policy-makers, 
a participant noted:
“Why aren’t the bed nets killing mosquitoes? 
Why are the indoor insecticide sprays not killing 
mosquitoes? We have heard a lot about mosquitoes 
being resistant to the insecticides, but I still think 
we have not answered the question of where the 
resistance is coming from; what causes it and how it 
can be prevented or corrected. And also, do people 
know that the insecticides no longer kill mosquitoes? 
And if this is already a common knowledge, why are 
we still using these insecticides? I am sure that it 
costs a great deal of money to treat all the bed nets in 
the country with insecticides; but if these insecticides 
no longer work as insecticides, then why are we still 
using them?” (Policy-maker, female).
Opinions on the potential of alternative interventions 
for malaria elimination
Discussions on alternative interventions for malaria elim-
ination were based on participants’ opinions about their 
effectiveness, sustainability, safety, as well as on their 
views on Tanzania’s readiness to adopt them. There was a 
wide diversity of opinions, as described below.
Improved housing
All stakeholder groups associated improved housing con-
ditions with reduced malaria risk. However, there were 
disagreements on whether the government should sup-
port the transition towards better living conditions in 
malaria endemic areas. While community members were 
strongly supportive of this idea, policy-makers were hesi-
tant, pointing out issues of sustainability, affordability, 
and competing government priorities.
Community members argued that no intervention 
would be fully effective without adequate housing. Spe-
cifically, they noted that none of the other interventions 
under discussion would be particularly useful if peo-
ple continued to live in poorly-constructed houses with 
gaps on walls, roofs, doors and eave spaces. They further 
stressed that the government could indeed afford provid-
ing better housing for the poorest community members 
living in areas with high malaria burden. Community 
members proposed several ways that the government 
could assist, such as by providing loans for people to 
build improved houses, subsidizing prices for building 
materials, or building and renting houses to the poorest 
at a reduced price. As one community member said:
“If the government could listen, I would advise 
them to assist people, especially the poor people, to 
build improved houses. They can maybe build the 
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houses, and people can repay the government slowly, 
everyone can pay according to what they can afford.” 
(Community member, female).
Policy-makers agreed that improved houses 
provide extra protection against malaria-transmitting 
mosquitoes. However, they were against the idea of 
the government building or modifying houses for poor 
people living in areas of high malaria transmission. They 
argued that it is not the responsibility of the government 
to build houses for citizens, and that given the required 
magnitude, the programme would be expensive and 
unsustainable. As one policy maker said:
“You know, our country is still poor, which means 
that a lot more people live in poverty than not. If you 
say that we start building or improving houses for all 
the poor people, then we will not have money for any 
of the other important things like health care and 
education.” (Policy-maker, female).
Policy-makers also indicated that building better 
houses alone would not be enough to eliminate 
malaria—a lot of effort would still be needed to ensure 
that mosquitoes are controlled in their larval habitats and 
hiding places.
Research scientists and regulators also agreed that it 
would be advantageous if poor people in malaria endemic 
areas had access to better housing. Nonetheless, they too 
noted that it would not be sustainable for the govern-
ment to support this initiative, or even to get funding to 
investigate its potential. As one scientist noted:
“For house improvement, no one denies that this 
works. The only problem is cost implications; that 
could be one of the reasons that this has not been 
taken up. Also, the way our research is organized 
and funded does not help in things like house 
improvement. It is difficult to get funding for 
[researching] this” (Scientist, male).
Larval source management
Two strategies were discussed: environmental manage-
ment and larviciding (Table  1). However, most of the 
interest was directed towards larviciding. One major 
issue voiced by all stakeholder groups was the lack of 
clear regulations and enforcement on environmental 
management regulations, especially in relation to settle-
ment planning and waste water management. Commu-
nity members complained about lack of regulations on 
where people build, cultivate crops or manufacture bricks 
for construction, which often results in the accumulation 
of standing water near settlements, increasing the risk of 
malaria and other mosquito-borne diseases. In the words 
of a community member:
“The town is rapidly growing now. There were 
parts of the town that people were allowed to 
make bricks in the past; no one lived there at 
the time. But now many people live there, and 
it is not safe because there are so many brick-
pits, hence so many mosquito breeding places…
It would be important if there were requirements, 
[for example] that the brick makers move to 
other unoccupied places, or [that] they should be 
required to fill in the pits” (Community member, 
female).
The use of larvicides for malaria control was 
perceived positively across the stakeholder groups, but 
with some caveats. Policy-makers strongly supported 
the use of bio-larvicides, stating that the government 
had invested on the creation of a bio-larvicide plant 
as part of the national strategy towards malaria 
elimination, but that use of the bio-larvicide remained 
low as one policy maker reported:
“The bio-larvicides we are producing are designed 
to only affect mosquitoes, so they are relatively safe 
on the environment. We expected a high uptake 
from community and civil organizations, but I am 
sad to say that we are getting more customers from 
outside the country than within the country….” 
(Policy-maker, female).
Research scientists were also supportive of larviciding 
for malaria elimination, but they noted that the 
efficacy of the locally produced bio-larvicides should 
be thoroughly evaluated, since any perception of low 
efficacy might cause low uptake.
While a majority of the community members were in 
favour of larviciding for malaria control, a few mem-
bers expressed concerns that there were so many water 
pools in their villages, particularly in the rainy season, 
that it would be difficult to treat all of them with lar-
vicides without harming the environment, particularly 
the fish. One person stated:
“I would also like to stress that I do not trust this 
idea of putting chemicals in water. We all know 
that all of this water makes its way into the river 
where we get our fish. If we treat all the pools then 
that means a lot of chemicals will be going to 
the river. Now, are you telling me that it will not 
harm the fish? Most of us are fishermen here and 
our fish is part of who we are. Anything that can 
harm the fish will not be welcomed here. Maybe 
if you want to put these chemicals, you can do it 
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during the dry season, but then there are not many 
mosquitoes during this time, so it will just be a 
waste” (Community member, male).
Mass drug administration (MDA) of the endectocide 
ivermectin
Mass drug administration with ivermectin is currently 
undergoing trials in Tanzania as a potential vector con-
trol tool but several already completed trials suggest the 
potential impact of this intervention on mosquito density 
and malaria burden [18, 55]. When given to humans and/
or cattle, the drug is effective in killing the mosquitoes 
that bite these hosts. The drug was widely known among 
all stakeholder groups as it is already widely distributed 
for control of lymphatic filariasis in humans [44, 45] and 
for several cattle diseases [56].
Community members referred to ivermectin as Usubi, 
and remembered health workers going from house to 
house every year encouraging people to take the drug 
for the control of Matende (elephantiasis) and Mabusha 
(hydrocele), conditions commonly associated with lym-
phatic filariasis. Despite the high awareness of this drug, 
there were mixed views among the stakeholder groups 
on its use for malaria control. Regulators, policy-makers 
and research scientists were hopeful and supportive of 
the approach, given its safety and effectiveness for the 
control and treatment of lymphatic filariasis in Tanzania. 
They argued that deploying it for the control of malaria-
carrying mosquitoes would represent an important 
advantage at relatively low cost. They also stressed the 
need to spend time and resources to educate and raise 
awareness of the benefits of ivermectin use among target 
communities.
Community members on the other hand, had strong 
objections to this intervention, reporting negative expe-
riences with previous mass drug administration (MDA) 
campaigns, particularly of praziquantel, commonly used 
for the treatment and control of schistosomiasis among 
school children. They reported that a number of children 
who receive the drug suffer fainting spells in schools. 
They also noted that people often avoided taking medi-
cines. One participant stated:
“I really must tell you that these medicines that 
you have to swallow have a challenge. When they 
brought Usubi, even with all the education and the 
advocacy they had provided, people still did not take 
the medicines. Some people just picked it so as not 
to make the health workers feel bad, but after they 
[health workers] left people threw the medicine 
away.” (Community member, male).
Targeted spraying of mosquito swarms
A great deal of scepticism was expressed by all stake-
holder groups about the sustainability and feasibility of 
targeted swarms of Anopheles mosquitoes with insec-
ticide spraying. It was noted that the approach would 
require extensive community participation to locate the 
swarms, and would be expensive. One participant stated
“The setback with this is that you need a lot of 
people to do that, so it may also be expensive. But 
I agree maybe you use less insecticides, but if you 
are worrying about the cost of the insecticides, you 
will still be spending more in paying people to spray” 
(Policy-maker, male).
Community members also pointed out that it would 
be inconvenient to spray at the time of the day when 
mosquitoes swarm—around sunset—and in most of the 
locations where they do so: “…it will be difficult to find 
someone at home during that time, people will still be 
at work, or they will be too tired to accept more work.” 
(Community member, male).
Mosquito modification technologies
The possibility of releasing modified mosquitoes gener-
ated a lot of discussions and resulted in polarized view-
points among all stakeholder groups. Although groups 
were introduced to different approaches to mosquito 
modification (i.e., sterile insect technique, genetically 
modified-sterile mosquitoes, and gene drive technology), 
most of the interest centered on implications of gene 
drive technologies, particularly those used for suppres-
sion of malaria vector populations.
Scientists expressed the most pointed criticisms of 
gene drive technology. They questioned its safety and 
the country’s readiness for this type of innovation. They 
also pointed out that there are still a lot of unknowns, 
and that long-term research would be needed to pro-
vide evidence on various aspects of the technology. They 
expressed concerns about the possibility of mutations in 
either the Plasmodium parasite or the modified mosqui-
toes themselves. Specific concerns in this case were that 
the modified malaria vectors could become vectors for 
other diseases, or that the parasite could mutate and sur-
vive in other mosquito species. The fact that the technol-
ogy would target a single species of malaria vectors was 
also seen as a risk, as it could increase the prevalence or 
vectorial capacity of other species. Targeting one mos-
quito species was also seen as a drawback in securing 
community acceptance. One participant stated:
“For the people, no malaria means no mosquitoes. 
They still cannot distinguish between malaria-
transmitting and non-malaria transmitting 
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mosquitoes, so if you tell them that you are 
controlling malaria then they need to see the 
mosquitoes gone.” (Scientist, female).
Scientists were also concerned by the fact that there 
were not many African and particularly Tanzanian 
scientists taking leading roles in this sort of research. As 
one scientist stated:
“There are more fears than certainty regarding this 
technology. It is mainly being driven by foreigners. I 
worry that there are not many African researchers 
participating in the detailed research of this 
technology” (Scientist, female).
Policy-makers were divided in their views regarding 
gene drives. Some were in favour of the technology, 
pointing out that it was environmentally friendly and 
required little compliance from communities, yet others 
were skeptical, noting that there is currently a great deal 
of controversy over genetically-modified food products, 
and that it might, therefore, be unwise to introduce 
another genetically-modified organism (GMO). One 
policy-maker said:
“We are already struggling with acceptance of GM 
crops. Adding yet something like this may bring 
havoc in the country. Let them [other countries] try 
it first, let us learn from our neighbours, and go last 
in this” (Policy maker, female). The policy makers 
also recognized that the technology is not yet ready, 
and cannot be considered in the context of a 2030 
malaria elimination target.
In contrast, and perhaps surprisingly, community 
members expressed a great deal of fascination with 
the technology. They were struck in particular by the 
fact that it would require little work or participation 
from local residents, compared to traditional malaria 
interventions. They also expressed a preference for this 
technology since it seemed to pose the least harm to the 
environment, particularly to fish. One participant said:
“I like that it does not have any chemicals, so the 
environment and the fish are all safe, but the 
malaria-mosquitoes will be gone (Community 
member, male).
Regulators pointed out that, while the potential of 
gene drive technologies ought to be explored, there are 
currently no adequate policies and regulations for their 
governance. Before those can be put in place, more 
research is needed to assure short- and long-term safety. 
One participant said:
“There are regulations for GMOs, but this technology 
you have is not GMO, rather gene-edited organisms. 
Gene-edited is not the same as GMO. We do not 
have policies or regulations for that. I believe you 
[the scientists] can advise us on this; provide all the 
information needed and the evidence of its safety 
and we can add this into the regulations concerning 
GM organisms” (Regulator, female).
Spatial repellents
All stakeholder groups agreed that this technology would 
be appropriate as a complementary (rather than primary) 
intervention for malaria control and elimination. Scien-
tists however indicated that there was still insufficient 
evidence to determine the best spatial repellents, their 
availability, cost and feasibility of use.
Community members spoke positively about spa-
tial repellents, saying they were most useful when peo-
ple were outdoors in early night hours, cooking, eating 
and relaxing with their family and friends before going 
indoors to sleep. They alleged that it would be best if the 
government could distribute bed nets together with spa-
tial repellents as a package, in order to tackle the prob-
lem of changes in mosquito behaviour. One participant 
stated:
“We have been told that mosquitoes are clever and 
have changed their biting times, so we have to be 
smart too and respond to that change using these 
repellents. If the government can provide these 
repellents to every household and teach them when, 
where and how to use them, I think we can make a 
very big progress in ending the malaria problem.” 
(Community member, female).
Discussion
This study explored opinions of key stakeholders on Tan-
zania’s progress towards malaria elimination, and on the 
suitability and potential value of six alternative interven-
tions that might be used to complement current efforts to 
achieve that goal in the future. The stakeholders weighed 
the pros and cons of alternative technologies for malaria 
control and elimination, rather than focusing their dis-
cussions on a single approach.
The findings reveal a considerable agreement across the 
stakeholder groups on the extent of progress achieved 
in the control of malaria in Tanzania over the last dec-
ade. It was also noted that policy makers, regulators 
and scientists pointed to statistical evidence of declin-
ing malaria prevalence, as reported in recent Tanzania’s 
malaria indicator surveys [3, 57], while community mem-
bers pointed mostly to the lived experiences of witness-
ing fewer episodes of malaria and reduced severity of 
the disease. All participants commended the country’s 
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efforts in providing universal coverage with LLINs, reli-
able diagnosis and affordable treatment, whose effective-
ness has been demonstrated in various studies [7, 58, 59]. 
There was also a general but not unanimous agreement 
that current interventions will not be sufficient to achieve 
further reductions of the malaria burden. Participants 
listed various challenges, such as insecticide resistance 
and outdoor biting exposure, which have been registered 
in many field studies [5, 7].
While there was a general consensus that new, comple-
mentary interventions or technologies will be needed to 
push the country further towards elimination, opinions 
differed on what technologies deserved prioritization 
and investment. The interventions with broadest sup-
port were larviciding and spatial repellents. Participants 
favoured spatial repellents for their low cost and ability to 
provide temporary relief against early-evening and out-
door-biting mosquitoes, thereby complementing LLINs. 
Support for larviciding could be found in all stakeholders 
as well, and it was the most preferred option among pol-
icy makers, regulators and research scientists. Commu-
nity members did not object strongly to it, but expressed 
concerns over its environmental impact, particularly on 
fish stocks, and favoured its use during the dry season to 
minimize the likelihood of water contamination. Current 
national policy already includes an expansion of larvicid-
ing as a means of achieving further reductions in malaria 
incidence [11].
Insecticide-spraying of mosquito swarms was the least 
preferred option for all stakeholder groups, due to per-
ceived environmental harm, high cost, and the assumed 
difficulty of area-wide implementation and scaling up. 
This view contrasted with a previous survey conducted 
in the Ulanga and Kilombero district on the same topic, 
which showed wide acceptance for the targeting of mos-
quito swarms [60]. This difference in opinions is likely 
due to the fact that the community members involved in 
the FGDs had no real experience with the intervention, 
compared to the community members who had been 
interviewed for the survey, all of whom had volunteered 
in a swarm targeting trial.
One surprising outcome of this study was the degree of 
skepticism that scientists expressed about the prospect of 
mosquito modification technologies, particularly those 
based on gene drive constructs—and, by the same token, 
the comparatively positive view expressed by commu-
nity members. This is a potential important observation 
since any introduction of gene drive-based methods for 
malaria control in Tanzania will require strong support 
by local scientists, because of basic operational reasons 
and the influence that scientists have on the perceptions 
of all the other stakeholder groups. Some of the con-
cerns discussed by scientists, such as their doubts about 
safety or the possibility undesirable mutations, can be 
addressed by further scientific research, but others, in 
particular their complaint about inadequate involve-
ment of African scientists in the development of the 
technology, will require changes in the social and politi-
cal organization of gene drive research for the control of 
vector-borne diseases. Similar concerns were observed in 
a recent study that explored perceptions of scientists in 
Nigeria on the potential release of genetically modified 
mosquitoes [61]. In this study, policy-makers and regula-
tors repeatedly noted they will rely on the advice of sci-
entists to make informed decisions. This emphasizes the 
persuasive power of scientists, and stresses the need to 
expand involvement of local scientists in the develop-
ment of the technology, and the need for further collabo-
ration between scientists, policy-makers and regulators 
in the development and evaluation of this technology.
Community members, in contrast, expressed support 
for gene drive technology. They perceived it as being 
environmentally safer, and noted that it would require 
little work by communities, a welcome contrast to most 
current interventions. This was an unexpected finding 
for us, and contrasts with studies conducted elsewhere 
that suggest significant opposition to the release of modi-
fied mosquitoes. A recent study from Mali, for instance, 
reveals the reluctance of community members to accept 
experimental releases of genetically modified mosqui-
toes in their villages, arguing that the technology should 
be first tried elsewhere to show evidence of safety [62]. 
A recent US study has shown that nearly two-thirds of 
respondents trusted universities and the department of 
agriculture (but not the private sector or the Department 
of Defence) to develop gene drives [63]. This study fur-
ther attests to the importance of gaining approval from 
local scientists, and the need to strengthen communica-
tion between scientists and communities in deliberating 
over the appropriateness of this technology. For inter-
ventions such as gene drives, this study also demon-
strates that additional engagement and training for local 
scientists will be necessary before the intervention trials 
proceed.
Community members expressed a strong preference for 
improvement in the built environment. They emphasized 
that improving houses was a more sustainable approach 
to malaria prevention, and would have a similarly positive 
impact on many other vector-borne diseases. This point 
of view is not surprising, and is supported by historical 
evidence linking successes against malaria to improved 
housing conditions in Europe and North America [64]. 
They also find support in recent studies showing sig-
nificant reductions in malaria transmission following 
improved housing materials or house screening [26, 37]. 
In contrast, scientists and policy makers were skeptical 
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about investing on housing improvement as a malaria 
control technology, mostly because of the perceived high 
cost and lack of political feasibility.
Mass drug administration with ivermectin also gener-
ated polarized views among the stakeholder groups. Pol-
icy-makers, regulators and scientists expressed a strongly 
positive view on this technology. In contrast, it generated 
significant opposition from community members, who 
reported negative previous experiences with MDAs cam-
paigns in primary schools for the treatment and control 
of schistosomiasis. This observation echoes studies con-
ducted in Tanzania and Cameroon showing that adher-
ence to ivermectin MDA was strongly associated with 
previous experiences of MDAs, even when they involved 
other drugs [65, 66]. Community members also pointed 
out that people did not generally like taking drugs, par-
ticularly when they did not suffer symptoms, which 
would limit the adoption of this approach.
This study had a number of limitations. Some of the 
interventions discussed in the FGDs were new or not 
very well known to some participants, and required a 
summary introduction by the facilitator. To minimize the 
influence of the facilitator on the discussion, participants 
were first asked to list and discuss the approaches they 
were familiar with, and only after they had exhausted 
what they knew were they offered an introduction to 
the other interventions. That introduction was generic; 
questions were often reverted back to the participants 
themselves to elucidate the reasons for their queries. In 
the discussion, an equal amount of time and information 
was given to each technology. Participants were generally 
very engaged with the discussion, and asked many ques-
tions before giving their opinion.
Conclusion
While it seems inevitable that new tools will be needed 
to achieve malaria elimination in Tanzania by 2030, it 
remains to be seen which particular combination of 
interventions will be adopted in the near future. Differ-
ent stakeholders perceive differently the advantages and 
disadvantages of each individual approach to malaria 
control and elimination, and assess individual options in 
the context of existing methods and other potential alter-
natives. All stakeholder groups, however, claimed that 
they rely on the advice provided by scientists to make 
informed decisions. This shows the critical role scientists 
play as gate-keepers for new interventions, and suggests 
the importance of a robust dialogue and clear commu-
nication between scientists, policy-makers, regulators 
and community members. Community members shared 
multiple thoughts on how the alternative interventions 
might work for them. Their willingness and in some 
cases eagerness to participate in efforts towards malaria 
elimination emphasizes the need to actively involve citi-
zens in the design, development and implementation 
of strategies to eliminate malaria, in Tanzania and else-
where. While scientists, regulators and policy-makers 
describe progress against malaria in terms of declining 
parasite prevalence, community members describe that 
same progress in terms of their daily life experiences. It 
is, therefore, vital to create an on-going dialogue between 
scientists, policy-makers, regulators and communities on 
any new interventions being considered for malaria con-
trol and elimination. Lastly, the need for local scientists 
to engage in development and evaluation of new technol-
ogies such as gene drives is desirable to promote uptake, 
should such technologies prove effective.
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